{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:03:45Z","timestamp":1791216225744,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.ahj.2007.06.024","type":"journal-article","created":{"date-parts":[[2007,9,23]],"date-time":"2007-09-23T07:12:11Z","timestamp":1190531531000},"page":"624-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":188,"title":["Rationale and design of a randomized clinical trial of \u03b2-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome"],"prefix":"10.1016","volume":"154","clinical-trial-number":[{"clinical-trial-number":"nct00429364","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Ronald V.","family":"Lacro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry C.","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Wruck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Colan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Devereux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. LuAnn","family":"Minich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Paridon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail D.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth F.","family":"Printz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reed E.","family":"Pyeritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Radojewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Philip","family":"Saul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario P.","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2007.06.024_bib1","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","article-title":"Marfan's syndrome","volume":"366","author":"Judge","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2007.06.024_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0002-9149(00)80066-1","article-title":"Life expectancy in the Marfan syndrome","volume":"75","author":"Silverman","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2007.06.024_bib3","first-page":"11","article-title":"Marfan syndrome: current and future clinical and genetic management of cardiovascular manifestations","volume":"5","author":"Pyeritz","year":"1993","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2007.06.024_bib4","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJM199904293401702","article-title":"Replacement of the aortic root in patients with Marfan's syndrome","volume":"340","author":"Gott","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2007.06.024_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2007.06.024_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/nar\/26.1.229","article-title":"Marfan database (third edition): new mutations and new routines for the software","volume":"26","author":"Collod-Beroud","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ahj.2007.06.024_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0945-053X(03)00014-3","article-title":"Codistribution analysis of elastin and related fibrillar proteins in early vertebrate development","volume":"22","author":"Visconti","year":"2003","journal-title":"Matrix Biol"},{"key":"10.1016\/j.ahj.2007.06.024_bib8","doi-asserted-by":"crossref","first-page":"14763","DOI":"10.1016\/S0021-9258(18)98752-1","article-title":"Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils","volume":"266","author":"Sakai","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ahj.2007.06.024_bib9","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/ki.1997.188","article-title":"Latent transforming growth factor\u2013beta: structural features and mechanisms of activation","volume":"51","author":"Munger","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2007.06.024_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1615\/CritRevEukaryotGeneExpr.v9.i1.30","article-title":"Regulation and regulatory activities of transforming growth factor beta","volume":"9","author":"Bonewald","year":"1999","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.ahj.2007.06.024_bib11","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1074\/jbc.M209256200","article-title":"Latent transforming growth factor beta\u2013binding protein 1 interacts with fibrillin and is a microfibril-associated protein","volume":"278","author":"Isogai","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ahj.2007.06.024_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1359\/jbmr.2000.15.1.68","article-title":"Role of the latent transforming growth factor beta binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo","volume":"15","author":"Dallas","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ahj.2007.06.024_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.ahj.2007.06.024_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ng1511","article-title":"A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2","volume":"37","author":"Loeys","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.ahj.2007.06.024_bib15","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1172\/JCI200422715","article-title":"TGF-beta\u2013dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome","volume":"114","author":"Ng","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2007.06.024_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ahj.2007.06.024_bib17","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","article-title":"Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome","volume":"330","author":"Shores","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2007.06.024_bib18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0002-9149(99)00101-0","article-title":"Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome","volume":"83","author":"Rossi-Foulkes","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2007.06.024_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0002-9149(94)90762-5","article-title":"Effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan syndrome","volume":"74","author":"Salim","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2007.06.024_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpeds.2006.09.003","article-title":"Beta-blocker therapy does not alter the rate of aortic root dilation in pediatric patients with Marfan syndrome","volume":"150","author":"Selamet Tierney","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.ahj.2007.06.024_bib21","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.amjcard.2005.01.032","article-title":"Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome","volume":"95","author":"Yetman","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2007.06.024_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/heart.88.1.97","article-title":"Management of Marfan syndrome","volume":"88","author":"Dean","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2007.06.024_bib23","doi-asserted-by":"crossref","first-page":"I282","DOI":"10.1161\/hc37t1.094856","article-title":"Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan's syndrome","volume":"104","author":"Nagashima","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.06.024_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00246-005-1151-9","article-title":"The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart disease","volume":"27","author":"Mahony","year":"2006","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.ahj.2007.06.024_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R","article-title":"Revised diagnostic criteria for the Marfan syndrome","volume":"62","author":"de Paepe","year":"1996","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ahj.2007.06.024_bib26","unstructured":"Greally, MT. Shprintzen-Goldberg syndrome. GeneReviews at GeneTests: Medical Genetics Information Resource (database online). 1-13-2006. University of Washington, Seattle. 1997-2006. 3-29-2006."},{"key":"10.1016\/j.ahj.2007.06.024_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ajmg.10312","article-title":"Growth and maturation in Marfan syndrome","volume":"109","author":"Erkula","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ahj.2007.06.024_bib28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/cpt1977216691","article-title":"Relationship between blood level of atenolol and pharmacologic effect","volume":"21","author":"Amery","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2007.06.024_bib29","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1161\/01.CIR.92.12.3415","article-title":"Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients","volume":"92","author":"Tuininga","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.06.024_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0003-4975(01)03236-2","article-title":"Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size","volume":"73","author":"Davies","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2007.06.024_bib31","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ehj.2004.04.033","article-title":"Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome","volume":"25","author":"Nollen","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2007.06.024_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.athoracsur.2005.06.026","article-title":"Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms","volume":"81","author":"Davies","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2007.06.024_bib33","series-title":"Applied longitudinal analysis","author":"Fitzmaurice","year":"2004"},{"key":"10.1016\/j.ahj.2007.06.024_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O'Brien","year":"1979","journal-title":"Biometrics"},{"key":"10.1016\/j.ahj.2007.06.024_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2307\/2336502","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrika"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870307005285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870307005285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:34:35Z","timestamp":1757568875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870307005285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0002870307005285"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2007.06.024","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of a randomized clinical trial of \u03b2-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2007.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}